Call us now for a FREE consultation!
1 (800) 339-4247

Displaying items by tag: hair loss study

Hair Loss Study: Scientists reverse aging-associated skin wrinkles and hair loss in a mouse model

A gene mutation causes wrinkled skin and hair loss; turning off that mutation restores the mouse to normal appearance.

Wrinkled skin and hair loss are hallmarks of aging. What if they could be reversed?

Keshav Singh, Ph.D., and colleagues have done just that, in a mouse model developed at the University of Alabama at Birmingham. When a mutation leading to mitochondrial dysfunction is induced, the mouse develops wrinkled skin and extensive, visible hair loss in a matter of weeks. When the mitochondrial function is restored by turning off the gene responsible for mitochondrial dysfunction, the mouse returns to smooth skin and thick fur, indistinguishable from a healthy mouse of the same age.

"To our knowledge, this observation is unprecedented," said Singh, a professor of genetics in the UAB School of Medicine.

Importantly, the mutation that does this is in a nuclear gene affecting mitochondrial function, the tiny organelles known as the powerhouses of the cells. Numerous mitochondria in cells produce 90 percent of the chemical energy cells need to survive.

In humans, a decline in mitochondrial function is seen during aging, and mitochondrial dysfunction can drive age-related diseases. A depletion of the DNA in mitochondria is also implicated in human mitochondrial diseases, cardiovascular disease, diabetes, age-associated neurological disorders and cancer.

"This mouse model," Singh said, "should provide an unprecedented opportunity for the development of preventive and therapeutic drug development strategies to augment the mitochondrial functions for the treatment of aging-associated skin and hair pathology and other human diseases in which mitochondrial dysfunction plays a significant role."

The mutation in the mouse model is induced when the antibiotic doxycycline is added to the food or drinking water. This causes depletion of mitochondrial DNA because the enzyme to replicate the DNA becomes inactive.

In four weeks, the mice showed gray hair, reduced hair density, hair loss, slowed movements and lethargy, changes that are reminiscent of natural aging. Wrinkled skin was seen four to eight weeks after induction of the mutation, and females had more severe skin wrinkles than males.

Dramatically, this hair loss and wrinkled skin could be reversed by turning off the mutation. The photos below show the hair loss and wrinkled skin after two months of doxycycline induction, and the same mouse a month later after doxycycline was stopped, allowing restoration of the depleted mitochondrial DNA.

Little change was seen in other organs when the mutation was induced, suggesting an important role for mitochondria in skin compared to other tissues.

The wrinkled skin showed changes similar to those seen in both intrinsic and extrinsic aging -- intrinsic aging is the natural process of aging, and extrinsic aging is the effect of external factors that influence aging, such as skin wrinkles that develop from excess sun or long-term smoking.

Among the details, the skin of induced-mutation mice showed increased numbers of skin cells, abnormal thickening of the outer layer, dysfunctional hair follicles and increased inflammation that appeared to contribute to skin pathology. These are similar to extrinsic aging of the skin in humans. The mice with depleted mitochondrial DNA also showed changed expression of four aging-associated markers in cells, similar to intrinsic aging.

The skin also showed disruption in the balance between matrix metalloproteinase enzymes and their tissue-specific inhibitor -- a balance of these two is necessary to maintain the collagen fibers in the skin that prevent wrinkling.

The mitochondria of induced-mutation mice had reduced mitochondrial DNA content, altered mitochondrial gene expression, and instability of the large complexes in mitochondria that are involved in oxidative phosphorylation.

Reversal of the mutation restored mitochondrial function, as well as the skin and hair pathology. This showed that mitochondria are reversible regulators of skin aging and loss of hair, an observation that Singh calls "surprising."

"It suggests that epigenetic mechanisms underlying mitochondria-to-nucleus cross-talk must play an important role in the restoration of normal skin and hair phenotype," Singh said, who has a secondary UAB appointment as professor of pathology. "Further experiments are required to determine whether phenotypic changes in other organs can also be reversed to wildtype level by restoration of mitrochondrial DNA."


Story Source:

Materials provided by University of Alabama at BirminghamNote: Content may be edited for style and length.


Journal Reference:

  1. Bhupendra Singh, Trenton R. Schoeb, Prachi Bajpai, Andrzej Slominski, Keshav K. Singh. Reversing wrinkled skin and hair loss in mice by restoring mitochondrial functionCell Death & Disease, 2018; 9 (7) DOI: 

PAGE CITATION:

University of Alabama at Birmingham. "Scientists reverse aging-associated skin wrinkles and hair loss in a mouse model: A gene mutation causes wrinkled skin and hair loss; turning off that mutation restores the mouse to normal appearance.." ScienceDaily. ScienceDaily, 20 July 2018. <www.sciencedaily.com/releases/2018/07/180720112808.htm>.

Hair Loss Study: Experimental drug reverses hair loss and skin damage linked to fatty diet, shows a new study in mice

The research advances the search for compounds that may someday accelerate wound healing and reverse balding in a series of experiments with mice, Johns Hopkins investigators have used an experimental compound to successfully reverse hair loss, hair whitening and skin inflammation linked by previous studies to human diets heavy in fat and cholesterol.

The investigators say the compound halts the production of certain fats called glycosphingolipids, or GSLs, that are major components of skin and other cell membranes. Current research shows that mice fed a diet high in fat and cholesterol are more likely to have hair discoloration from black to gray to white, extensive hair loss and inflammation of skin exhibited by multiple wounds. Feeding these animals the compound, however, appears to reverse such symptoms.

The Hopkins investigators caution that such results in mice do not mean that the same effects would occur in people, and there is no evidence at this time that the compounds they used would be safe in people. But the findings, they say, do shed light on possible pathways for addressing hair loss and skin wounds in humans with oral or topical medications.

A report on the findings was published July 30 in Scientific Reports.

"Further research is needed, but our findings show promise for someday using the drug we developed for skin diseases such as psoriasis, and wounds resulting from diabetes or plastic surgery," says Subroto Chatterjee, Ph.D., M.S., M.Sc., professor of pediatrics and medicine at the Johns Hopkins University School of Medicine. Chatterjee conducts research as part of Johns Hopkins Children's Center.

More specifically, previous studies showed that GSLs are prevalent in the cells that make up the uppermost layer of the skin, as well as in cells called keratinocytes that help regulate pigmentation of the eyes, skin and hair.

To determine how disrupting GSLs might affect skin appearance and color, and whether treatment with D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (D-PDMP) -- a human-made compound that halts GSL production -- would reverse any negative effects, Chatterjee and his colleagues first genetically modified a group of mice to have atherosclerosis, a disease in which arteries are clogged by fat deposits.

The researchers then fed one group of these mice a Western diet high in fat and cholesterol, and a second group standard chow. All mice were fed their assigned diets from 12 weeks of age to 20 weeks.

Compared to those fed standard chow, the mice that ate a Western diet lost hair, formed skin lesions and suffered from hair whitening. These results became more severe when the mice continued eating a Western diet for 36 weeks, with 75 percent of the mice having skin, hair loss and multiple skin lesions.

From 20 to 36 weeks of age, mice in both groups were given varying amounts of D-PDMP, either in a capsule or as a liquid, while they ate the same diet. Mice that received 1 milligram and 10 milligrams of D-PDMP in a capsule per kilogram of body weight from 20 to 36 weeks while eating a Western diet started regaining hair and hair color, and their skin inflammation lessened. Treatment with 1 milligram of D-PDMP in a capsule per kilogram of body weight was as effective as 10 milligrams per kilogram as a liquid. This suggests that an encapsulated form of D-PDMP is a better method of drug delivery.

The research team then looked at the skin of the mice's under a microscope and found that mice eating the Western diet experienced an infiltration of neutrophils, a type of white blood cell implicated in inflammation, in various skin areas. Treatment with D-PDMP in a capsule significantly reduced the number of neutrophils, implying reduced skin inflammation and wounding.

Next, the researchers used mass spectrometry analysis, a method of identifying and quantifying the chemical composition of a mixture, to determine ceramide, glucosylceramide and lactosylceramide levels in the mice. Ceramides are a type of lipid, or fat, that helps protect the skin's moisture, and glucosylceramide is the first derivative of ceramide, whereas lactosylceramide, a later derivative of ceramide, activates inflammation.

Compared to mice fed normal chow, those fed a Western diet had decreased total ceramide levels, decreased glucosylceramide and nearly three times more lactosylceramide. Treatment with 1 milligram of D-PDMP in a capsule per kilogram of body weight or 10 milligrams of D-PDMP as a liquid per kilogram of body weight, however, noticeably increased ceramide levels to normal.

"Our findings show that a Western diet causes hair loss, hair whitening and skin inflammation in mice, and we believe a similar process occurs in men who lose hair and experience hair whitening when they eat a diet high in fat and cholesterol," says Chatterjee.

More animal research needs to be done to confirm and expand on the findings, and to determine how well and what amount of D-PDMP might heal wounds and activate hair growth.

"Hopefully someday in the future this can mean faster, more effective recovery from baldness, hair whitening in aging populations and wound healing," says Chatterjee.

Other authors on this paper include Djahida Bedja, Wenwen Yan, Dominica Iocca, Veera Ratnam Bandaru and Nickesh Ramakrishnan of the Johns Hopkins University School of Medicine, and Wenwen Yan of Tongji University.

This study was funded by the National Institutes of Health (PO1HL10715301).


Story Source:

Materials provided by Johns Hopkins MedicineNote: Content may be edited for style and length.


Journal Reference:

  1. Djahida Bedja, Wenwen Yan, Viren Lad, Domenica Iocco, Nickash Sivakumar, Veera Venkata Ratnam Bandaru, Subroto Chatterjee. Inhibition of glycosphingolipid synthesis reverses skin inflammation and hair loss in ApoE−/− mice fed western dietScientific Reports, 2018; 8 (1) DOI: 

PAGE CITATION: Johns Hopkins Medicine. "Experimental drug reverses hair loss and skin damage linked to fatty diet, shows new study in mice: The research advances search for compounds that may someday accelerate wound healing and reverse balding." ScienceDaily. ScienceDaily, 30 July 2018. <www.sciencedaily.com/releases/2018/07/180730090152.htm>.

A new drug could ease the distress of men and women who suffer from baldness, according to researchers from The University of Manchester's Centre for Dermatology Research. 

The study from the laboratory of Prof Ralf Paus is published today (May 8, 2018) in the open access journal PLOS Biology. It shows that a drug originally designed as a treatment for osteoporosis has a dramatic stimulatory effect on human hair follicles donated by patients undergoing hair transplantation surgery. Currently, only two drugs -- minoxidil and finasteride -- are available for treatment of male-pattern balding (androgenetic alopecia). However, both agents have moderate side effects and often produce disappointing hair regrowth results. The only other option available to patients is hair transplantation surgery. The Ph.D. project, led by Dr. Nathan Hawkshaw and colleagues, sought to develop new ways to promote human hair growth with the hope of finding novel, well-tolerated agents for treating androgenetic alopecia.

The approach was to first identify the molecular mechanisms of an old immunosuppressive drug, Cyclosporine A (CsA). Cyclosporine A has been commonly used since the 1980s as a crucial drug that suppresses transplant rejection and autoimmune diseases. However, it often has severe side-effects, the least serious -- but most interesting -- of which is that it enhances cosmetically unwanted hair growth.

The team carried out a full gene expression analysis of isolated human scalp hair follicles treated with CsA. This revealed that CsA reduces the expression of SFRP1, a protein that inhibits the development and growth of many tissues, including hair follicles. This identifies a completely novel mechanism of action of this old and widely used immunosuppressant. The research also explains why CsA so often induces undesired hair growth in patients as it removes an inbuilt and potent molecular brake on human hair growth. The inhibitory mechanism is completely unrelated to CsA's immunosuppressive activities, making SFRP1 a new and highly promising therapeutic target for anti-hair loss strategies.

After some detective work, Dr Hawkshaw found that a compound originally developed to treat osteoporosis, called WAY-316606, targets the same mechanism as CsA by specifically antagonizing SFRP1. When he then treated hair follicles with WAY-316606, the unrelated agent also effectively enhanced human hair growth like CsA. The external application of WAY-316606 or similar compounds to the balding human scalp, he argued, may promote hair growth to the same magnitude as CsA or even better, but without its side effects.

Dr Hawkshaw said: "Thanks to our collaboration with a local hair transplant surgeon, Dr. Asim Shahmalak, we were able to conduct our experiments with scalp hair follicles that had generously been donated by over 40 patients and were then tested in organ cultures. "This makes our research clinically very relevant, as many hair research studies only use cell culture."

He added: "When the hair growth-promoting effects of CsA were previously studied in mice, a very different molecular mechanism of action was suggested; had we relied on these mouse research concepts, we would have been barking up the wrong tree. "The fact this new agent, which had never even been considered in a hair loss context, promotes human hair growth is exciting because of its translational potential: it could one day make a real difference to people who suffer from hair loss.

"Clearly though, a clinical trial is required next to tell us whether this drug or similar compounds are both effective and safe in hair loss patients."

 

Story Source: Materials provided by University of Manchester


Journal Reference:

  1. Nathan J. Hawkshaw, Jonathan A. Hardman, Iain S. Haslam, Asim Shahmalak, Amos Gilhar, Xinhong Lim, Ralf Paus. Identifying novel strategies for treating human hair loss disorders: Cyclosporine A suppresses the Wnt inhibitor, SFRP1, in the dermal papilla of human scalp hair folliclesPLOS Biology, 2018; 16 (5): e2003705 DOI: 10.1371/journal.pbio.2003705
Tagged under

African-American women are prone to hair loss, and new data presented at the American Academy of Dermatology's 74th Annual Meeting in Washington illustrates the scope of this problem, which often goes undiagnosed. Certain styling practices may increase the risk of hair loss in this population; women who are concerned about losing their hair should consider different styling practices and see a dermatologist if they notice any signs of hair loss.

AMERICAN ACADEMY OF DERMATOLOGY EXPERT

Information provided by board-certified dermatologist Yolanda M. Lenzy, MD, FAAD, clinical associate, University of Connecticut, Farmington, Conn.

CAUSES OF HAIR LOSS

According to Dr. Lenzy, the No. 1 cause of hair loss in African-American women is a condition called central centrifugal cicatricial alopecia (CCCA), a disorder in which inflammation and destruction of hair follicles causes scarring and permanent hair loss. She says this population is also prone to traction alopecia, a type of hair loss caused by styles that pull the hair too tight. In addition to these conditions, she says, African-American women also may be affected by other hair disorders like female pattern baldness.

Women pay an average of 40 percent more than men for minoxidil foams -- a hair loss remedy most commonly known as Rogaine -- according to a new analysis from researchers at the Perelman School of Medicine at the University of Pennsylvania. The price difference appears despite the fact that the men's and women's version of the products -- which are branded and marketed differently -- contain the same drug strength and inactive ingredients. JAMA Dermatology published the findings online.

"Gender-based consumer price differences are well-documented, but we believe this is the first analysis comparing the pricing of medication along gender lines," said Jules Lipoff, MD, an assistant professor of Dermatology and the study's lead author.

An estimated 50 million men and 30 million women in America have androgentic alopecia -- otherwise known as male-pattern or female-pattern baldness. With men, it usually presents as a receding hairline, while in women, it usually causes thinning of the hair. A recent study found the global market for treatments of this condition will reach $11.8 billion by the year 2024.

Male-pattern baldness and premature greying are associated with a more than fivefold risk of heart disease before the age of 40 years, according to research presented at the 69th Annual Conference of the Cardiological Society of India (CSI). Obesity was associated with a fourfold risk of early heart disease.

Tagged under
Friday, 16 March 2018 19:00

Hair Loss Study: Seasonality of Hair Loss

A new British Journal of Dermatology study explores the relationship between seasonality and hair loss at a population level using Google Trends data. Across all eight countries analyzed in the study, summer and fall were associated with greater hair loss.

The findings support previous studies that were constrained by small sample sizes or homogeneous populations in limited geographic locations. The physiology of hair loss as related to seasonal variation is unknown, however.

"This study synthesized digital epidemiological data from both hemispheres to confirm the clinical suspicion that the summer and fall seasons are associated with greater hair loss," said senior author Dr. Shawn Kwatra, of the Johns Hopkins University School of Medicine. "This finding is clinically relevant for patients presenting in the summer and fall months with worsened hair loss and has implications in assessing the effectiveness of therapies. Future research will further clarify this association and examine the physiology of the hair cycle."

Story Source: Materials provided by Wiley.

Wiley. "Seasonality of hair loss." ScienceDaily. ScienceDaily, 24 October 2017. <www.sciencedaily.com/releases/2017/10/171024103031.htm>.

Tagged under

Researchers have developed a method for the mass preparation of cellular aggregates, also known as 'hair follicle germs (HFGs)', that may lead to a new treatment for hair loss.

Although hair loss is not life-threatening, it troubles a substantial number of individuals all over the world, particularly in aging societies. Hair regenerative medicine has emerged as a new therapy to combat the problem. The therapy involves regenerating hair follicles, the tiny organs that grow and sustain hair. One of the more challenging obstacles to hair regenerative medicine has been the preparation of hair follicle germs, the reproductive source of hair follicles, on a large scale.

The paper, published in the journal Biomaterials, reports the successful preparation of up to 5000 HFGs simultaneously and reports new hair growth from the HFGs after transplantation into mice.

"The key for the mass production of HFGs was a choice of substrate materials for culture vessel," says the corresponding author Junji Fukuda, Professor, Yokohama National University. "We used oxygen-permeable dimethylpolysiloxane (PDMS) at the bottom of culture vessel, and it worked very well."

The research group further evaluated the feasibility of this method by transferring the prepared HFGs from a fabricated approximately 300-microwell array, called "HFG chip," to generate hair follicles and hairs on the mouse body. The group confirmed black hair generation at both the back and scalp transplantation sites. The regenerated hair exhibited the typical hair cycle of murine hair.

"This simple method is very robust and promising. We hope that this technique will improve human hair regenerative therapy to treat hair loss such as androgenic alopecia," adds Fukuda. "In fact, we have preliminary data that suggests human HFG formation using human keratinocytes and dermal papilla cells."

Story Source: Materials provided by Yokohama National University.

Yokohama National University. "Practical hair regeneration technology: Researchers develop a method for large-scale preparation of hair-producing tissues." ScienceDaily. ScienceDaily, 1 February 2018. <www.sciencedaily.com/releases/2018/02/180201142853.htm>.

Tagged under
Sunday, 02 October 2016 19:00

WNT Pathway Study for Hair Growth

New Hair Growth Study Has Promising Results

The secret to restoring and regrowing hair has long been an elusive one, but Angela Christiano may have found the secret. A long-time sufferer of alopecia areata, a condition well-known for causing hair loss, Christiano has found a way to grow a full head of hair in a laboratory setting.

Christiano, a researcher at Columbia University, was not satisfied with the limited options for women's hair growth. Instead of settling for 20-year-old medications, Christiano decided to take matters into her own hands by using a patient's own stem cells to grow hair which could later be transplanted to bald spots.

Christiano is on the forefront of a movement in the biotech community to treat severe hair loss as a medical condition. While this may sound intimidating, it means that those suffering from hair loss may finally get some current and effective medical treatments for their issues. 

How is this different from current treatments? Well, many people mistakenly treat hair loss as a cosmetic issue rather than a medical concern. Part of this misconception comes from how flat-out difficult it has proven to try to regrow hair.

And unfortunately, there are no shortages of ways for men and women to lose their hair. One of the most common ways is through alopecia areata, a condition which causes that immune system to see hair as a virus and subsequently attack the hair follicles. 

REPORT: Efficacy of Treatments Compared for Female Pattern Hair LossEfficacy of Treatment Compared for Female Hair Loss

As of July 2015, there have been no less than 47 reported studies on several popular topical treatments for female pattern hair loss (FPHL) that included approximately 5300 women ranging in age from 27 to 57. Within these studies, there were 3 small sub-studies on a topical treatment used for male hair loss. No age was provided on the ages of the 231 male participants. Twenty-one of the studies were viewed as bias-free, meaning that there were no outside influences, and 26 studies were financed by pharmaceutical firms which were viewed as having a moderate risk of being biased.

Each participant provided information about family history of hair loss. Additional pre-study information was collected on whether a person was pre or post-menopausal, how the impact of thinning hair affected their self-confidence, discomfort, emotional stress, and quality of life. In those cases where hair regrowth or improved density was noticed, the participants reported an improvement in their self-confidence and quality of life.

CATEGORIES OF STUDIES:


Minoxidil Compared to a Placebo:
In these studies twice as many women experienced moderate regrowth with the minoxidil than with the placebo. The mild side effects described by both group participants were: dermatitis, skin irritation, and itching scalp.

Minoxidil 2% Compared to Minoxidil 5%:
The results of these studies indicated that while there was an increase in hair regrowth, there were no significant benefits gained from the group using the higher concentration of minoxidil from the group using the lower concentration. The same mild side effects of dermatitis, skin irritation and itching scalp were reported by both female groups.

Finasteride Compared to a Placebo:
Three studies on the use of the male topical treatment, finasteride, compared to a placebo showed the same level of improvement. The mild side effects identified by both groups were the same, but the studies did not describe those comments.

Laser Comb Therapy Compared to Sham Therapy:
The results of these two studies revealed that both groups saw a healthy increase in hair regrowth. There were no side effects reported by either group.

FPHL is the most common hair problem for women, occurring most often at the front and over the top of the head. Topical hair treatments are similar to other health care routines; people must continue their routines in order to retain the benefits. Minoxidil is not recommended for lactating or pregnant women.

Page 1 of 2